Logo image of SYENS.BR

SYENSQO SA (SYENS.BR) Stock Fundamental Analysis

EBR:SYENS - Euronext Brussels - BE0974464977 - Common Stock - Currency: EUR

67.85  -0.85 (-1.24%)

Fundamental Rating

4

SYENS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 67 industry peers in the Chemicals industry. SYENS has an average financial health and profitability rating. SYENS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SYENS had positive earnings in the past year.
SYENS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SYENS reported negative net income in multiple years.
SYENS had a positive operating cash flow in each of the past 5 years.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -0.89%, SYENS is in line with its industry, outperforming 40.30% of the companies in the same industry.
SYENS has a Return On Equity (-1.50%) which is in line with its industry peers.
The Return On Invested Capital of SYENS (4.59%) is better than 64.18% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SYENS is above the industry average of 6.29%.
Industry RankSector Rank
ROA -0.89%
ROE -1.5%
ROIC 4.59%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 9.06%, SYENS is in the better half of the industry, outperforming 70.15% of the companies in the same industry.
In the last couple of years the Operating Margin of SYENS has declined.
SYENS has a Gross Margin (31.61%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SYENS has remained more or less at the same level.
Industry RankSector Rank
OM 9.06%
PM (TTM) N/A
GM 31.61%
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SYENS is creating some value.
Compared to 1 year ago, SYENS has less shares outstanding
Compared to 1 year ago, SYENS has an improved debt to assets ratio.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

SYENS has an Altman-Z score of 2.27. This is not the best score and indicates that SYENS is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.27, SYENS is doing good in the industry, outperforming 61.19% of the companies in the same industry.
SYENS has a debt to FCF ratio of 23.55. This is a negative value and a sign of low solvency as SYENS would need 23.55 years to pay back of all of its debts.
SYENS has a Debt to FCF ratio (23.55) which is comparable to the rest of the industry.
SYENS has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
SYENS's Debt to Equity ratio of 0.25 is fine compared to the rest of the industry. SYENS outperforms 68.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 23.55
Altman-Z 2.27
ROIC/WACC0.67
WACC6.83%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.58 indicates that SYENS should not have too much problems paying its short term obligations.
The Current ratio of SYENS (1.58) is comparable to the rest of the industry.
SYENS has a Quick Ratio of 1.58. This is a bad value and indicates that SYENS is not financially healthy enough and could expect problems in meeting its short term obligations.
SYENS has a worse Quick ratio (0.96) than 61.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.96
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

The earnings per share for SYENS have decreased strongly by -102.63% in the last year.
SYENS shows a decrease in Revenue. In the last year, the revenue decreased by -3.10%.
The Revenue has been growing slightly by 4.31% on average over the past years.
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.14%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-0.31%

3.2 Future

SYENS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.94% yearly.
The Revenue is expected to grow by 3.14% on average over the next years.
EPS Next Y6.78%
EPS Next 2Y12%
EPS Next 3Y12.22%
EPS Next 5Y7.94%
Revenue Next Year1.22%
Revenue Next 2Y2.83%
Revenue Next 3Y3.48%
Revenue Next 5Y3.14%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.28, which indicates a correct valuation of SYENS.
Based on the Price/Earnings ratio, SYENS is valued a bit cheaper than 79.10% of the companies in the same industry.
SYENS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.18.
With a Price/Forward Earnings ratio of 10.26, the valuation of SYENS can be described as very reasonable.
89.55% of the companies in the same industry are more expensive than SYENS, based on the Price/Forward Earnings ratio.
SYENS is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.34, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.28
Fwd PE 10.26
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

79.10% of the companies in the same industry are more expensive than SYENS, based on the Enterprise Value to EBITDA ratio.
SYENS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 80.12
EV/EBITDA 6.28
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SYENS's earnings are expected to grow with 12.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.11
PEG (5Y)N/A
EPS Next 2Y12%
EPS Next 3Y12.22%

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.61%, SYENS has a reasonable but not impressive dividend return.
SYENS's Dividend Yield is comparable with the industry average which is at 2.99.
SYENS's Dividend Yield is slightly below the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.61%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of SYENS are negative and hence is the payout ratio. SYENS will probably not be able to sustain this dividend level.
DP-157.41%
EPS Next 2Y12%
EPS Next 3Y12.22%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 500M -500M -1B

SYENSQO SA

EBR:SYENS (7/16/2025, 2:40:03 PM)

67.85

-0.85 (-1.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)07-31 2025-07-31
Inst Owners23.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.05B
Analysts80.74
Price Target84.21 (24.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.61%
Yearly Dividend1.63
Dividend Growth(5Y)N/A
DP-157.41%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-21.73%
Min EPS beat(2)-38.67%
Max EPS beat(2)-4.8%
EPS beat(4)0
Avg EPS beat(4)-15.85%
Min EPS beat(4)-38.67%
Max EPS beat(4)-4.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.74%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)-1.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.43%
PT rev (3m)-6.74%
EPS NQ rev (1m)-5.77%
EPS NQ rev (3m)-11.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.61%
Revenue NQ rev (1m)-2.1%
Revenue NQ rev (3m)-5.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.58%
Valuation
Industry RankSector Rank
PE 14.28
Fwd PE 10.26
P/S 1.04
P/FCF 80.12
P/OCF 9.12
P/B 0.98
P/tB 2.3
EV/EBITDA 6.28
EPS(TTM)4.75
EY7%
EPS(NY)6.61
Fwd EY9.74%
FCF(TTM)0.85
FCFY1.25%
OCF(TTM)7.44
OCFY10.96%
SpS65.45
BVpS69.42
TBVpS29.46
PEG (NY)2.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.89%
ROE -1.5%
ROCE 6.12%
ROIC 4.59%
ROICexc 4.89%
ROICexgc 8.72%
OM 9.06%
PM (TTM) N/A
GM 31.61%
FCFM 1.29%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
ROICexc(3y)9.08%
ROICexc(5y)8.08%
ROICexgc(3y)19%
ROICexgc(5y)18.92%
ROCE(3y)11.29%
ROCE(5y)10.17%
ROICexcg growth 3Y-19.3%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.3%
ROICexc growth 5YN/A
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 23.55
Debt/EBITDA 1.3
Cap/Depr 91.58%
Cap/Sales 10.07%
Interest Coverage 250
Cash Conversion 56.67%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 0.96
Altman-Z 2.27
F-Score5
WACC6.83%
ROIC/WACC0.67
Cap/Depr(3y)98.43%
Cap/Depr(5y)76.05%
Cap/Sales(3y)9.47%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.14%
EPS Next Y6.78%
EPS Next 2Y12%
EPS Next 3Y12.22%
EPS Next 5Y7.94%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-0.31%
Revenue Next Year1.22%
Revenue Next 2Y2.83%
Revenue Next 3Y3.48%
Revenue Next 5Y3.14%
EBIT growth 1Y-33.42%
EBIT growth 3Y-0.36%
EBIT growth 5YN/A
EBIT Next Year51.65%
EBIT Next 3Y21.42%
EBIT Next 5Y14.93%
FCF growth 1Y-48.94%
FCF growth 3Y-7.48%
FCF growth 5YN/A
OCF growth 1Y-34.04%
OCF growth 3Y7.55%
OCF growth 5YN/A